Global Healthcare Leader Selects Kneat Kneat has signed a Master Services Agreement with a global provider of critical care products with over 50,000 employees.

Kneat Announces Closing of $20 Million Bought Deal Including Full Exercise of Over-Allotment Option Kneat announced the closing of its bought deal: it issued 6,153,880 common shares at $3.25 per share for gross proceeds of $20,000,110.

Kneat to Announce 2023 Fourth-Quarter and Fiscal Year Financial Results February 21, 2024 Kneat will announce its Q4 2023 results on February 21, 2024 after market close and host a call for investors the following morning.